US EditionPublished • loading... • Updated
Novo Shares Rise Nicely After Pill Approval in the Us
Summary by Jyllands-Posten
2 Articles
2 Articles
There has been little good news for Novo Nordisk in 2025, but on one of the last trading days of the year, the price of the pharmaceutical stock increases considerably. On Tuesday, Novo shares are trading 5.7 percent...
·Aarhus, Denmark
Read Full Article
Novo Nordisk has received approval for its Wegovy weight loss pill in the US, and the stock is showing signs of improvement on Tuesday morning. The approval gives the pharmaceutical giant a head start in a rapidly growing market, says an analyst.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
